Product Categories
| Country: | China |
|---|---|
| Tel: | 021-65675885 |
| Mobile: | 18964387627 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| F-1 | C22H27ClN8O3S | 2244775-31-1 | Details |
| CHMFL-PI3KD-317 | C21H24ClN5O3S2 | 2244992-76-3 | Details |
| SGC-AAK1-1 | C21H25N5O3S | 2247894-32-0 | Details |
| AAPK-25 | C21H13Cl2N3O2S | 2247919-28-2 | Details |
| 2H-Pyrido[2',1':3,4]pyrazino[1,2-b]indazole-3-carboxylic acid, 6-(1,1-dimethylethyl)-6,7-dihydro-10-(3-methoxypropoxy)-2-oxo-, (6R)- | C23H27N3O5 | 2247932-38-1 | Details |
| SN-008 | C25H19FN2O3S | 2249106-01-0 | Details |
| CRT0066854 hydrochloride | C24H26ClN5S | 2250019-91-9 | Details |
| SHIP2-IN-1 | C17H13Cl2FN4O | 2252247-80-4 | Details |
| TH5427 | C20H20Cl2N8O3 | 2253744-56-6 | Details |
| CVN424 | C24H29F2N5O3 | 2254706-21-1 | Details |
| UCM-1306 | C14H14FNO2S | 2258608-78-3 | Details |
| Compound 227105-11-5 | C16H14O3 | 227105-11-5 | Details |
| MARK4 inhibitor 1 | C20H18N6O3 | 2271081-58-2 | Details |
| WEE1-IN-3 | C28H31N7O2 | 2272976-28-8 | Details |
| Proquazone | C18H18N2O | 22760-18-5 | Details |
| Msr-Ratio | C18H14O3S | 2290635-22-0 | Details |
| 2-Methoxy-4-{(E)-3-oxo-3-[(E)-2-oxo-3-(3,4,5- trimethoxybenzylidene)piperidin-1-yl]prop-1-en-1-yl}phenyl acetate | C27H29NO8 | 2293951-00-3 | Details |
| (E)-1-[(E)-3-(4-hydroxy-3-methoxyphenyl)acryloyl]-3- (3,4,5-trimethoxybenzylidene) piperidin-2-one | C25H27NO7 | 2293951-01-4 | Details |
| anti-TB agent 1 | C23H19F3N4O3 | 2294013-78-6 | Details |
| IMT1 | C21H21NO4 | 2304621-31-4 | Details |
| FLT3-IN-4 | C23H25N7O2 | 2304799-09-3 | Details |
| ENFENAMIC ACID | C15H15NO2 | 23049-93-6 | Details |
| PDE9-IN-1 | C17H23FN6O2 | 2305087-92-5 | Details |
| TD-165 | C46H59N7O8S | 2305936-56-3 | Details |
| IU1-248 | C20H23N3O2 | 2307472-03-1 | Details |
| CRT0066101 dihydrochloride(956121-30-5 free base) | 2308510-39-4 | Details |
| CMP-5 2HCl | C21H22ClN3 | 2309409-79-6 | Details |
| BuChE-IN-TM-10 | C32H38N2O3 | 2313524-95-5 | Details |
| SET 2 | C17H21F3N4O2S | 2313525-20-9 | Details |
| TRPV4 agonist-1 free base | C25H22F2N4O2 | 2314467-59-7 | Details |
| 2,6-Dibromo-4-(hydroxymethyl)phenol | C7H6Br2O2 | 2316-62-3 | Details |
| LY3405105 | C26H39N7O3 | 2326428-25-3 | Details |
| IRE1α kinase-IN-1 | C26H26ClFN8 | 2328097-41-0 | Details |
| (S,R,S)-AHPC-PEG2-NH2 dihydrochloride | C28H42ClN5O6S | 2341796-76-5 | Details |
| dBRD9 HCl | C40H46ClN7O10 | 2341840-98-8 | Details |
| PD-1-IN-22 | C25H25N5O4 | 2349372-98-9 | Details |
| GA-017 | C18H21N3O4 | 2351906-74-4 | Details |
| Enbezotinib | C21H21FN6O3 | 2359649-81-1 | Details |
| RBN-3143 | C22H28FN3O4S | 2360853-16-1 | Details |
| CHIKV-IN-2 | C23H26N2O2 | 2361289-44-1 | Details |
| CWHM-1552 | C22H27F2N3O | 2368253-58-9 | Details |
| BRM/BRG1 ATP Inhibitor-2 | C20H20N4O2S2 | 2368900-77-8 | Details |
| C/EBPα inducer 1 | C20H12FN3O4 | 2374285-52-4 | Details |
| ms48107 | C23H20FN5O2 | 2375070-79-2 | Details |
| K-Ras G12C-IN-4 | C31H33ClN4O4 | 2376328-55-9 | Details |
| DS08210767 | C31H39N5O2 | 2376334-75-5 | Details |
| M2N12 | C20H16ClN5O2 | 2376577-06-7 | Details |
| SU056 | C20H16FNO5 | 2376580-08-2 | Details |
| Thalidomide-O-C4-NH2 hydrochloride | C17H20ClN3O5 | 2376990-29-1 | Details |
| Thalidomide-O-amido-C6-NH2 hydrochloride | C21H27ClN4O6 | 2376990-31-5 | Details |
| Tubulin inhibitor 24 | C22H21N3O3 | 2415761-65-6 | Details |
| NAcM-OPT HCl(2089293-61-6 free base) | C23H30Cl3N3O | 2416146-10-4 | Details |
| KB-0742 dihydrochloride | C16H26ClN5 | 2416874-75-2 | Details |
| XL177A | C48H57ClN8O5 | 2417089-74-6 | Details |
| cis VH 032, amine dihydrochloride | C22H31ClN4O3S | 2376990-32-6 | Details |
| 2-{[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl]amino}acetic acid | 2377032-39-6 | Details |
| AGI-43192 | C23H16ClF3N6O | 2377491-54-6 | Details |
| SCR130 | C19H13Cl2N3O2S | 2377858-38-1 | Details |
| 1-(4-chloro-3-(trifluoromethyl)phenyl)-3-(7-(1-methyl-1H-pyrazol-4-yl)-2,3,4,9-tetrahydro-1H-carbazol-3-yl)urea | C24H21ClF3N5O | 2379727-88-3 | Details |
| Antitumor agent-19 | C24H21ClF3N5O | 2379727-90-7 | Details |
| Reverse transcriptase-IN-1 | C25H17N7O2 | 2380001-43-2 | Details |
| Nampt-IN-5 | C25H25N5O2 | 2380013-17-0 | Details |
| DC-TEADin02 | C19H17NO2S | 2380228-45-3 | Details |
| BOS-318 | C28H32Cl2N6O3 | 2387633-15-8 | Details |
| P2Y2R/GPR17 antagonist 1 | C19H13ClN2O6S | 2395016-49-4 | Details |
| Pumecitinib | C17H20N8O2S | 2401057-12-1 | Details |
| HS271 | C21H24F3N5O2 | 2410393-15-4 | Details |
| Compound TPX-0046 | 2411115-73-4 | Details |
| 3-amino-1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]propan-1-one dihydrochloride | C25H28ClN7O2 | 2411178-94-2 | Details |
| Hamaline | C20H19ClN2O | 2411677-02-4 | Details |
| Sivopixant | C25H22ClN5O5 | 2414285-40-6 | Details |
| (S)-ErSO | C22H13F6NO3 | 2407860-34-6 | Details |
| 2-((2,2-Dibenzylhydrazineylidene)methyl)pyridine | C20H19N3 | 237402-29-8 | Details |
| LMPTP INHIBITOR 1 hydrochloride | C28H37ClN4O | 2310135-38-5 | Details |
| nerolidol acetate | C17H28O2 | 2306-78-7 | Details |
| BUR1 | C16H17N5 | 23000-46-6 | Details |
| BAY 2666605 | C17H12F4N2O2 | 2275774-60-0 | Details |
| UMB298 | C27H31ClN4O2 | 2266569-73-5 | Details |
| Epitinib succinate | C28H32N6O6 | 2252334-12-4 | Details |
| MERS-CoV-IN-1 | C19H17NO2 | 2245697-92-9 | Details |
| 1-(2-hydroxyethyl)thymine | C7H10N2O3 | 22441-51-6 | Details |
| Thalidomide-5-NH2-CH2-COOH | C15H13N3O6 | 2412056-27-8 | Details |
| BCL6-IN-6 | C27H31FN6O2S | 2408882-54-0 | Details |
| PLN-1474 | C24H37N3O4 | 2408065-32-5 | Details |
| DS12881479 | C16H19N3OS | 2373065-59-7 | Details |
| SRI-37330 | C16H19F3N4O2S | 2322245-42-9 | Details |
| HM43239 | C29H33ClN6 | 2294874-49-8 | Details |
| visamminol-3'-O- glucoside | C21H26O10 | 2254096-98-3 | Details |
| HeE1-2Tyr | C33H30N2O6S | 2245195-67-7 | Details |
| CDK12-IN-2 | C32H32N6O2 | 2244987-03-7 | Details |
| ANT3310 | C6H10FN2NaO5S | 2410688-61-6 | Details |
| NF-κΒ activator 1 | C16H11FN2O2S | 2387524-59-4 | Details |
| Auristatin23 | C49H84N6O10 | 2375388-36-4 | Details |
| 5,6-Epoxyergosterol | C28H44O2 | 23637-31-2 | Details |
| AES-135 | C33H29F6N3O5S | 2361659-61-0 | Details |
| Mito-LND | C43H45BrCl2N3OP | 2361564-49-8 | Details |
| WSB1 Degrader 1 | C21H22N2O2 | 2306039-66-5 | Details |
| DDO-7263 | C14H9F2N3O | 2254004-96-9 | Details |
| AHR antagonist 5 free base | C25H24FN7 | 2247950-42-9 | Details |
| ACSS2-IN-2 | C21H19F2N3O4 | 2332820-04-7 | Details |
| Product Total： Product Page： | ||||
| 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 | ||||